The J-shaped relationship between coronary heart disease and achieved blood pressure level in treated hypertension: further analyses of 12 years of follow-up of treated hypertensives in the Primary Prevention Trial in Gothenburg, Sweden
- 1 June 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 8 (6), 547-555
- https://doi.org/10.1097/00004872-199006000-00008
Abstract
The relationship between the blood pressure level achieved through antihypertensive treatment and the incidence of coronary heart disease (CHD) was studied in 686 middle-aged hypertensive men. The patients studied came from a random population sample and were followed-up for 12 years, yielding a total of 6563 patient-years for the study. Eighty-seven patients suffered a non-fatal myocardial infarction or died from CHD. The incidence of CHD showed a J-shaped distribution in relation to achieved treated systolic and diastolic blood pressure levels. The incidence of CHD, adjusted for entry characteristics, age, serum cholesterol, blood pressure and smoking habits, decreased with reductions in blood pressure achieved through treatment, to a level of about 150/85 mmHg, below which the incidence rate again increased. This J-shaped pattern was also observed when data from patients with pre-existing signs or symptoms of ischemic heart disease at entry were excluded. Using a quadratic term as the best fit to the observed relationship between achieved treated diastolic blood pressure level and the incidence of CHD, a Cox regression analysis showed that the nadir of the J-shaped incidence curve was at a diastolic blood pressure value of 81 mmHg. There did not seem to be any association between the absolute size of the blood pressure reduction during treatment and the incidence of CHD. Although we cannot exclude the possibility that the increased incidence of CHD in patients with a low treated blood pressure is due primarily to pre-existing but subclinical ischemic heart disease, our findings indicate that an excessive lowering of blood pressure in hypertensive patients may be harmful. Therefore, until the optimal blood pressure goal on treatment has been better defined through specifically designed treatment studies, we suggest that a diastolic blood pressure level of 80-85 mmHg is the lowest that should be sought as treatment goal in middle-aged, male hypertensive patients.This publication has 10 references indexed in Scilit:
- Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction.BMJ, 1988
- THE RELATION BETWEEN DEGREE OF BLOOD PRESSURE REDUCTION AND MORTALITY AMONG HYPERTENSIVES IN THE HYPERTENSION DETECTION AND FOLLOW-UP PROGRAMAmerican Journal of Epidemiology, 1988
- WHY DOES ANTIHYPERTENSIVE TREATMENT PREVENT STROKE BUT NOT MYOCARDIAL INFARCTION?The Lancet, 1987
- BENEFITS AND POTENTIAL HARM OF LOWERING HIGH BLOOD PRESSUREThe Lancet, 1987
- SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MENThe Lancet, 1986
- HYPERTENSION IN MIDDLE-AGED MEN - MANAGEMENT, MORBIDITY AND PROGNOSTIC FACTORS DURING LONG-TERM HYPERTENSIVE CARE1985
- THE IMPACT OF SELECTED INDICES OF ANTIHYPERTENSIVE TREATMENT ON ALL-CAUSE MORTALITYAmerican Journal of Epidemiology, 1983
- Treatment of mild hypertension: A five year controlled drug trialAmerican Journal Of Medicine, 1980
- RELATION OF REDUCTION IN PRESSURE TO FIRST MYOCARDIAL INFARCTION IN PATIENTS RECEIVING TREATMENT FOR SEVERE HYPERTENSIONThe Lancet, 1979
- RE-EXAMINATION OF SOME OF THE FRAMINGHAM BLOOD-PRESSURE DATAThe Lancet, 1978